The role of lineage specifiers in pancreatic ductal adenocarcinoma
- PMID: 30603119
- PMCID: PMC6286940
- DOI: 10.21037/jgo.2018.05.04
The role of lineage specifiers in pancreatic ductal adenocarcinoma
Abstract
Over the last decade, multiple genomics studies have led to the identification of discrete molecular subtypes of pancreatic ductal adenocarcinoma. A general theme has emerged that most pancreatic ductal adenocarcinoma (PDAC) can be grouped into two major subtypes based on cancer cell autonomous properties: classical/pancreatic progenitor and basal-like/squamous. The classical/progenitor subtype expresses higher levels of lineage specifiers that regulate endodermal differentiation than the basal-like/squamous subtype. The basal-like/squamous subtype confers a worse prognosis, raising the possibility that loss of these lineage specifiers might enhance the malignant potential of PDAC. Here, we discuss several of these differentially expressed lineage specifiers and examine the evidence that they might play a functional role in PDAC biology.
Keywords: Lineage specifier; molecular subtype; transcription factor.
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Figures
Similar articles
-
Reciprocal regulation of pancreatic ductal adenocarcinoma growth and molecular subtype by HNF4α and SIX1/4.Gut. 2021 May;70(5):900-914. doi: 10.1136/gutjnl-2020-321316. Epub 2020 Aug 21. Gut. 2021. PMID: 32826305 Free PMC article.
-
Cell Lineage Infidelity in PDAC Progression and Therapy Resistance.Front Cell Dev Biol. 2021 Dec 2;9:795251. doi: 10.3389/fcell.2021.795251. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34926472 Free PMC article. Review.
-
ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer.bioRxiv [Preprint]. 2024 Mar 13:2024.03.12.584316. doi: 10.1101/2024.03.12.584316. bioRxiv. 2024. Update in: Carcinogenesis. 2024 Nov 22;45(11):845-856. doi: 10.1093/carcin/bgae056. PMID: 38903083 Free PMC article. Updated. Preprint.
-
Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma.BMC Cancer. 2016 Aug 12;16:632. doi: 10.1186/s12885-016-2540-6. BMC Cancer. 2016. PMID: 27520560 Free PMC article. Clinical Trial.
-
Molecular and Metabolic Subtypes Correspondence for Pancreatic Ductal Adenocarcinoma Classification.J Clin Med. 2020 Dec 21;9(12):4128. doi: 10.3390/jcm9124128. J Clin Med. 2020. PMID: 33371431 Free PMC article. Review.
Cited by
-
KMT2D links TGF-β signaling to noncanonical activin pathway and regulates pancreatic cancer cell plasticity.Int J Cancer. 2023 Aug 1;153(3):552-570. doi: 10.1002/ijc.34528. Epub 2023 May 4. Int J Cancer. 2023. PMID: 37140208 Free PMC article.
-
Establishment of a reference single-cell RNA sequencing dataset for human pancreatic adenocarcinoma.iScience. 2022 Jun 22;25(8):104659. doi: 10.1016/j.isci.2022.104659. eCollection 2022 Aug 19. iScience. 2022. PMID: 35847558 Free PMC article.
-
The Role of lncRNAs in the Stem Phenotype of Pancreatic Ductal Adenocarcinoma.Int J Mol Sci. 2021 Jun 15;22(12):6374. doi: 10.3390/ijms22126374. Int J Mol Sci. 2021. PMID: 34203589 Free PMC article. Review.
-
Unveiling the Molecular Landscape of Pancreatic Ductal Adenocarcinoma: Insights into the Role of the COMPASS-like Complex.Int J Mol Sci. 2024 May 7;25(10):5069. doi: 10.3390/ijms25105069. Int J Mol Sci. 2024. PMID: 38791111 Free PMC article. Review.
-
Pancreatic Cancer Cells Induce MicroRNA Deregulation in Platelets.Int J Mol Sci. 2022 Sep 28;23(19):11438. doi: 10.3390/ijms231911438. Int J Mol Sci. 2022. PMID: 36232741 Free PMC article.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources